AN IN-VITRO STUDY OF TIGECYCLINE SUSCEPTIBILITY AMONG MULTIDRUG RESISTANT BACTERIA IN A TERTIARY CARE HOSPITAL
DOI:
https://doi.org/10.7439/ijbr.v3i4.370Abstract
Background and objectives: Emergence and spread of antibiotic resistance among bacteria pose a challenge to clinicians due to limited therapeutic options available. Multi drug resistant (MDR) bacteria are known to cause life threatening infections in intensive care settings. Tigecycline is a newer glycycline antibiotic, considered as therapeutic option for MDR gram positive and gram negative bacteria. Aim of this study was to evaluate in-vitro susceptibility of tigecycline in MDR bacteria. Methods : We studied the in-vitro activity of tigecycline in 100 MDR bacteria isolated from blood, skin, soft tissue and surgical site infections, urine, sputum, bronchoalveolar lavage, CSF and other body fluids of patients admitted to a tertiary care hospital in South India. MDR bacteria tested for tigecycline susceptibility by disc diffusion and E-test included: Methicillin resistant S.aureus (MRSA) (35), extended spectrum β lactamase (ESBL) producing Enterobacteriaceae (36), P.aeruginosa (15) and Acinetobacter spp . (14). Results: Tigecycline was found effective against all isolates of MRSA (MIC90 0.25Downloads
Download data is not yet available.
Downloads
Published
2012-05-01
Issue
Section
Original Research Articles
License
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
- An author must submit Copyright form After acceptance of the article.
How to Cite
1.
AN IN-VITRO STUDY OF TIGECYCLINE SUSCEPTIBILITY AMONG MULTIDRUG RESISTANT BACTERIA IN A TERTIARY CARE HOSPITAL. Int Jour of Biomed Res [Internet]. 2012 May 1 [cited 2026 Mar. 11];3(4):192-5. Available from: https://ssjournals.co.in/index.php/ijbr/article/view/731